David Estapé, PhD

Senior Fellow - Biopharmaceutical Process

Basel, Switzerland

David is a recognized biotechnology thought leader. Throughout his career, he has led or supported design and provided GMP consulting services for clients within the biotech, vaccine and blood plasma pharmaceutical industries. With a strong interest in new technologies and regulatory trends, he participates heavily in organizations like BioPhorum and the International Society for Pharmaceutical Engineering.  

David’s primary area of focus as a technology manager for biotechnology clients is to provide all regions of the world with value-add insights and experience for front-end engineering process technologies, regulatory/Good Manufacturing Practice, advanced facility design and strategic planning.  

Insights By David

How the automation pyramid enables commercial-scale ATMP manufacturing

Use the automation pyramid as a roadmap to navigate the transition from lab-scale ATMP manufacturing to a cGMP facility that’s compliant, optimized, and future-ready.

Read More
Commercial Scale ATMP Manufacturing

6 questions to ask before transitioning to commercial-scale ATMP manufacturing

To move advanced therapy medicinal products (ATMPs) from the lab to the commercial-scale manufacturing facility, you need a future-proof plan. These 6 questions will help you create one.

Read More